Alvogen Croatia

Avenija Veceslava Holjevca 40
HR - 10 000

+385 1 6641 830
+385 1 6641 853

Alvogen opened its office in Zagreb in October 2011. Market focus is on sales and marketing of biosimilar and generic hospital products. Croatian team currently has six dedicated people, led by Ivana Stojcevic, Country Manager.

Croatian pharmaceutical market reached a value of $1,2 billion and it is one of the biggest markets in the region, though with only 4.5 million inhabitants.

Through strategic alliances, smart portfolio development and a strong sales team, Alvogen goal is to keep a leader position in bringing high-tech products such as biosimilars and top quality hospital generics to Croatian market.

Market info

The Croatian pharmaceutical market has been traditionally generic, with domestic Gx manufacturers holding large controlling shares.  Market share of generics is 40% in value and 65% in volume. Total market showed slow growth in 2011 vs 2010 (3%). Gx market is stagnating in value, mostly due to price decrease. However, hospital market increased 24% (2011 vs 2010). It is still driven by originators, Gx penetration is only 18%.

  • $1.2BCroatian pharmaceutical
    market in 2011
  • 4.6%Projected CAGR of
    pharmaceutical market by 2016
  • 65%Gx penetration
    in volume
  • 40%Gx penetration
    in value

Life at Alvogen Croatia